Hospital-acquired infections (HAIs) are driving extended hospitalizations, increased mortality rates, and billions in global healthcare losses. But today, healthcare facilities have access to emerging technologies that can significantly reduce pathogen exposure and predict infection risks — before they escalate.
Frost & Sullivan’s latest analysis provides a comprehensive look at growth opportunities in HAI prevention technologies. Discover how robotic sterilization, smart surveillance are changing hospital infection control workflows — backed by strategic investments, partnerships, and new business models like Robotics-as-a-Service (RaaS).
What You’ll Learn
-
Autonomous Disinfection and Sterilization Technologies
AI-integrated robots using ultraviolet-C (UV-C) and plasma systems for consistent, eco-friendly sterilization. -
Smart Monitoring and Predictive Surveillance Platforms
Biosensor-based systems and clinical decision support systems (CDSS) enabling real-time infection prediction and mitigation.
Will your organization lead the shift to predictive, tech-enabled infection prevention?
Fill in the form to download your exclusive copy now.
Explore Growth Opportunities
Strategic Imperatives Reshaping the HAI Prevention Technology Landscape
Disruptive Technologies
The focus is shifting from reactive to predictive strategies. Fully autonomous robotic sterilization systems and smart surveillance platforms are minimizing human intervention, reducing exposure risks, and enabling real-time, data-led infection mitigation.
Industry Convergence
HAI prevention is being redefined by the integration of robotics, AI, Internet of Things (IoT), and digital health infrastructure. Healthcare providers are adopting connected platforms that leverage data from electronic health records (EHRs), sterilization compliance, and hygiene tracking to support predictive infection control.
Innovative Business Models
Hospitals are moving toward outcome-driven models such as Robotics-as-a-Service (RaaS) and Software-as-a-Service (SaaS), offering scalable access to advanced infection prevention technologies without the burden of high upfront capital investment.
Why Frost & Sullivan
Frost & Sullivan’s growth opportunity analyses combine industry foresight, competitive benchmarking, and innovation tracking to help you identify and act on the most critical shifts in healthcare technology.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on store.frost.com.
*$1,000 honorarium is subject to eligibility
